Stratus, Zeto Partnership Expands EEG Access in Hospitals

IRVING, Texas and RALEIGH, N.C., Oct. 15, 2026 /CourierPR/ -- Stratus and Zeto have announced a strategic partnership aimed at expanding access to point-of-care EEG (electroencephalogram) in hospitals across the United States. The collaboration brings together Zeto's FDA-cleared point-of-care EEG device, Zeto ONE, with Stratus' nationwide network of Registered EEG Technologists (R. EEG T's). This partnership is designed to address a critical shortage of qualified EEG Technologists, who are essential for the accurate and continuous monitoring of patients in the Intensive Care Unit (ICU) and Emergency Department (ED).

Currently, EEG remains one of the most under-resourced diagnostic tools in acute care settings, primarily due to a chronic shortage of qualified EEG Technologists. This shortage constrains the widespread adoption of EEG technology, as it requires specialized personnel to apply the devices and provide continuous oversight. The Stratus-Zeto partnership seeks to bridge this gap by providing hospitals with a scalable solution that combines Zeto's rapid, full-montage EEG headsets with Stratus' clinical operations and nationwide network of R. EEG T's.

Stratus, a leading provider of neurodiagnostic solutions in the United States, will serve as the exclusive channel distributor for Zeto ONE in hospitals. This partnership allows hospitals to access Zeto ONE's novel, rapid-application EEG hardware and AI tools, which are designed to be intuitive and fast enough for bedside staff to apply at the point of care. However, the full-montage signal quality and continuous, technologist-verified oversight that neurologists rely on to catch critical neurological events as they happen remain a critical component of EEG monitoring.

Zeto, a next-generation neurotechnology company, brings rapid, guided setup and full-head coverage, including synchronized video and ECG, to the bedside. Stratus' remote R. EEG T's provide the 24/7, eyes-on monitoring and technical review that helps turn raw data into clinically actionable insights. The partnership builds on an existing clinical relationship between the two companies, which earlier this year launched NeuroNotis, a report that pairs Zeto ONE's AI-enabled seizure burden detection with technical validation from Stratus' R. EEG T's.

The Stratus-Zeto partnership is designed to offer hospitals a single, turnkey path to reliable, continuous EEG monitoring in the ICU, ED, and beyond. This scalable solution addresses the critical shortage of EEG Technologists by providing hospitals with a device that can be easily deployed and managed, while ensuring the quality and accuracy of EEG data. The partnership also aims to expand EEG access across the continuum of care, from routine testing to emergency and intensive care settings.

Zeto ONE is now available in hospitals through Stratus, which offers an array of EEG solutions, including remote ICU and EMU monitoring, world-class EEG review software, ambulatory VEEGs with pruned data, and custom EEG solutions tailored to meet hospitals' needs. The company also provides EEG solutions for centralized and decentralized clinical trials, biomarker detection, and access to over 2.2 million hours of anonymized EEG data through its R&D division's database.

The partnership between Stratus and Zeto is expected to significantly improve EEG access and quality in hospitals, particularly in the ICU and ED, where timely brain monitoring can make a substantial difference in clinical decision-making. This collaboration exemplifies how innovative technology and clinical expertise can work together to address critical healthcare challenges, ensuring that EEG monitoring is available to more patients across the country.